Organisation
Basic (bio-) Medical Sciences
Department
Basic and applied biomedical research, and biomedical science-based higher education.
Current researchers
41 - 50 of 155 results
- Rong Fan (Member)
- Beatrice Paola Festa (Member)
- Lorenzo Franceschini (Member)
- Fangye Gao (Member)
- Fréderick Garrousse (Member)
- Robin Gens (Member)
- Brecht Ghesquiere (Member)
- Manjusha Ghosh (Member)
- Kajangi Gnanachandran (Member)
- Ellen Goossens (Member)
Projects
41 - 50 of 141
- Backup mandate from Research Council: TITAN: imaging and manipulation of Tumor-Infiltrating T-cells using Anti-CD3 NanobodiesFrom1 Nov 2021 → 1 Nov 2021Funding: BOF - doctoral mandates
- TBM project: LATFIA-trial: Laser Assisted Treatment of Fistula In AnoFrom1 Oct 2021 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Pancreatic cancer and its subtypes: spatial profiling, mechanism of spatial cell positioning and potential cell of originFrom1 Oct 2021 → TodayFunding: BOF - ZAP BOF mandates
- Interdisciplinary Network in Fundamental and Medical Research on Lung and Pancreatic Cancer [NITROGEN]From1 Jul 2021 → TodayFunding: BOF - projects
- Creation of a 3D CRiMe scene to unravel Cytotoxicity Resistant Mechanisms in non-small cell lung cancer.From1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- Fertility preservation in boys treated for cancer: evaluating the impact of harvesting testicular tissue at young age on the later pubertal development and fertility (prospective study)From1 Jan 2021 → 31 Dec 2022Funding: FWO Humanitarian research project Stand up against Cancer
- Synthetic organogenesis: the role of blood vessels in orchestrating the development and morphogenesis of ectopic miniorgansFrom1 Jan 2021 → TodayFunding: BOF - iBOF
- Identifying and targeting the support of never healing wounds, cancer associated fibroblasts in liver tumorsFrom1 Jan 2021 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
- IOF PoC “MOTIF: MOdification of T cells In situ for altered Functionality”From1 Jan 2021 → 31 Dec 2022Funding: IOF - technology concept exploration
- ProteinContour: proteome-scale unraveling of the relation between post-translational modifications, biophysical properties, interactions and sub-cellular location of proteins.From1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 1112
- PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF
Authors: Christos Sachpekidis, Hartmut Goldschmidt, Dirk Hose, Leyun Pan, Caixia Cheng, Klaus Kopka, Uwe Haberkorn, Antonia Dimitrakopoulou-Strauss
Pages: 1343-1353 - Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6
Authors: Mathias Witzens-Harig, Dirk Hose, Simone Jünger, Christina Pfirschke, Nisit Khandelwal, Ludmila Umansky, Anja Seckinger, Heinke Conrad, Bettina Brackertz, Thierry Rème, et al.
Pages: 4493-4503 - Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone
Authors: Katja C Weisel, Christof Scheid, Manola Zago, Britta Besemer, Elias K Mai, Mathias Haenel, Jan Duerig, Markus Munder, Hans-Walter Lindemann, Anja Seckinger, et al.
- DNA repair pathways in human multiple myeloma
Authors: Claire Gourzones-Dmitriev, Alboukadel Kassambara, Surinder S Sahota, Thierry Rème, Jérôme Moreaux, Pascal Bourquard, Dirk Hose, Philippe Pasero, Angelos Constantinou, Bernard Klein
Pages: 2760-2773 - Daratumumab for systemic AL amyloidosis
Authors: Christoph R Kimmich, Tobias Terzer, Axel Benner, Tobias Dittrich, Kaya Veelken, Alexander Carpinteiro, Timon Hansen, Hartmut Goldschmidt, Anja Seckinger, Dirk Hose, et al.
Pages: 1517-1530 - Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma
Authors: Isabelle Herth, Mathias Witzens-Harig, Philipp Beckhove, Dirk Hose, Tobias Meissner, Brigitte Neuber, Melanie Engelhardt, Jürgen Haas, Kai Neben, Anthony D Ho, et al.
Pages: 231-240 - The histone deacetylase SIRT2 stabilizes Myc oncoproteins
Authors: P Y Liu, N Xu, A Malyukova, Christopher J Scarlett, Y T Sun, X D Zhang, D Ling, S-P Su, Claudia Benitez-Nelson, David K Chang, et al.
Pages: 503-514 - Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma
Authors: Niels Weinhold, Desiree Kirn, Anja Seckinger, Thomas Hielscher, Martin Granzow, Uta Bertsch, Gerlinde Egerer, Hans J Salwender, Igor W Blau, Katja Weisel, et al.
Pages: e116-e119 - Hitting the target without pulling the trigger.
Authors: Thierry VandenDriessche, Marinee K Chuah
Pages: 4-6 - Combinatorial strategies for the induction of immunogenic cell death.
Authors: L Bezu, LC Gomes-de-Silva, Heleen Dewitte, Karine Breckpot, J Fucikova, Radek Spisek, Lorenzo Galluzzi, Oliver Kepp, Guido Kroemer